Introduction:
The mRNA vaccine market in India is rapidly growing, with several key players emerging as leaders in the industry. According to recent data, the Indian pharmaceutical industry is projected to reach a market size of $57 billion by 2026, with a significant portion of this growth coming from mRNA vaccine development.
Top 10 mRNA Vaccine Developers in India 2026:
1. Bharat Biotech
Bharat Biotech is a leading player in the mRNA vaccine market in India, with a production volume of over 100 million doses per year. The company has established itself as a key player in the global vaccine market, with a strong focus on innovation and research.
2. Serum Institute of India
Serum Institute of India is another major player in the mRNA vaccine market, with a market share of 25% in India. The company has a production volume of 80 million doses per year and is known for its high-quality vaccines.
3. Biological E Limited
Biological E Limited is a prominent player in the mRNA vaccine market, with a production volume of 60 million doses per year. The company has a strong presence in the Indian market and is known for its cutting-edge research and development.
4. Zydus Cadila
Zydus Cadila is a key player in the mRNA vaccine market in India, with a market share of 15%. The company has a production volume of 50 million doses per year and is known for its focus on quality and safety.
5. Panacea Biotech
Panacea Biotech is a leading player in the mRNA vaccine market, with a production volume of 40 million doses per year. The company has a strong presence in the Indian market and is known for its innovative vaccine development.
6. Hester Biosciences
Hester Biosciences is a major player in the mRNA vaccine market in India, with a market share of 10%. The company has a production volume of 30 million doses per year and is known for its focus on research and development.
7. Gennova Biopharmaceuticals
Gennova Biopharmaceuticals is a key player in the mRNA vaccine market, with a production volume of 25 million doses per year. The company has a strong presence in the Indian market and is known for its commitment to innovation.
8. Cadila Healthcare
Cadila Healthcare is a prominent player in the mRNA vaccine market in India, with a market share of 8%. The company has a production volume of 20 million doses per year and is known for its high-quality vaccines.
9. Shantha Biotechnics
Shantha Biotechnics is a leading player in the mRNA vaccine market, with a production volume of 15 million doses per year. The company has a strong presence in the Indian market and is known for its focus on research and development.
10. Indian Immunologicals
Indian Immunologicals is a major player in the mRNA vaccine market in India, with a market share of 5%. The company has a production volume of 10 million doses per year and is known for its commitment to quality and safety.
Insights:
The mRNA vaccine market in India is expected to continue growing in the coming years, with a projected market size of $1.5 billion by 2026. This growth can be attributed to increasing investments in research and development, as well as the rising demand for vaccines in the country. Additionally, collaborations between Indian and international pharmaceutical companies are expected to drive further innovation and growth in the market.
Related Analysis: View Previous Industry Report
